Therapeutic Targeting of Left Atrial Myopathy in Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction
- 1 May 2020
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA Cardiology
- Vol. 5 (5) , 497-499
Abstract
This Viewpoint argues for the systematic identification of left atrium myopathy to guide tailored therapy in atrial fibrillation and heart failure with preserveKeywords
This publication has 10 references indexed in Scilit:
- TCT-87 Levoatrial to Coronary Sinus Shunting as a Novel Strategy for Symptomatic Heart Failure: First-in-Human ExperienceJACC, 2019
- Atrial Functional Mitral RegurgitationJACC, 2019
- Prognostic and functional implications of left atrial late gadolinium enhancement cardiovascular magnetic resonanceJournal of Cardiovascular Magnetic Resonance, 2019
- A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection FractionCirculation, 2018
- Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trialEuropean Heart Journal, 2018
- Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure])Circulation, 2018
- Prognostic Utility and Clinical Significance of Cardiac Mechanics in Heart Failure With Preserved Ejection FractionCirculation: Cardiovascular Imaging, 2016
- Left Atrial Decompression Pump for Severe Heart Failure With Preserved Ejection FractionJACC: Heart Failure, 2015
- Incremental Diagnostic Value of LA Strain With Leg Lifts in Heart Failure With Preserved Ejection FractionJACC: Cardiovascular Imaging, 2013
- Downregulation of Endocardial Nitric Oxide Synthase Expression and Nitric Oxide Production in Atrial FibrillationCirculation, 2002